TP53 and neoplasm: All five biomarkers (IDH1, TP53 and TERTp mutation status and MGMT and ATRX protein expression levels) remained unchanged in 25 cases during recurrence, suggesting that these recurrences might represent direct expansion of the primary residual tumour and may stem from linear clonal evolution38.